MAM
FedEx launches a new campaign ‘Connect your Business to a Changing World’
MUMBAI: Export transportation company, FedEx Express (FedEx), a subsidiary of FedEx Corp has launched a new campaign, ‘Connect your Business to a Changing World‘.
The campaign provides business leaders access to content about the trends impacting businesses and economies worldwide, as well as the solutions FedEx provides to help companies benefit from those trends.
FedEx Asia Pacific president David L Cunningham Jr said, “If global trade were its own free-standing economy, its GDP would exceed $18.3 trillion. This presents unprecedented opportunities for businesses of all sizes and in all countries. In this hyper-connected economy, businesses are able to take advantage of these opportunities through FedEx extraordinary global network and connectivity.”
FedEx services senior vice president, global marketing Rajesh Subramaniam said, “Turbulence in the global economy has exerted multiple pressures on businesses around the world as they look for ways to get ahead and remain competitive. This new multi-channel campaign and the http://connect.fedex.com experience provides businesses the intelligence to stay one step ahead of their customers‘ needs and to focus on a number of topics critical to achieving business and economic growth around the world.”
In addition to advertising across pan-regional, local print, and online media, the campaign will also be supported by a worldwide communications and public relations program.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
